Mineralocorticoid Receptor Antagonists and Aldosterone Synthase Inhibitors: Agent Comparison With Implications for Clinical Practice and Trial Design
Journal of Cardiac Failure · 2026
DOI: 10.1016/j.cardfail.2025.05.002 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Cardiac Failure, 2026. Verfasst von João Pedro Ferreira und 5 weiteren Autor:innen. Beteiligte Einrichtung: UnIC@RISE, Cardiovascular Research and Development Center, Department of Surgery and Physiology, Faculty of Medicine of the University of Porto, Port…. Hauptthemen laut MEDLINE: Mineralocorticoid Receptor Antagonists, Cytochrome P-450 CYP11B2, Heart Failure, Clinical Trials as Topic. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 76 Literaturangaben.
Abstract (Originalsprache)
Steroidal (s) and nonsteroidal (ns) mineralocorticoid receptor antagonists (MRAs) and aldosterone synthase inhibitors (ASis) are either available for clinical use or are being tested in clinical trials in cardiovascular, kidney and metabolic (CKM) conditions. All agents block the actions of aldosterone, but they present important differences in terms of modes of action, pharmacokinetics and dynamics and side-effect profiles. Such differences may have clinical implications. To ascertain such potential differences, we performed a description and indirect comparison of MRA and ASi trial results in hypertension, chronic kidney disease and heart failure. Whenever possible, we used data from head-to-head comparisons. We then used this information to provide clinical guidance and to suggest how to improve clinical trials in the future. Notably, by performing more head-to-head comparison trials and trials with dual or triple combination therapies with sodium glucose co-transporter 2 inhibitors (SGLT2is) and/or oral glucagon-like peptide 1 receptor agonists (GLP1ras). In short, this article focuses on the similarities and potential differences among MRAs, nsMRAs and ASis, with implications for both clinical use and clinical trial design.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- UnIC@RISE, Cardiovascular Research and Development Center, Department of Surgery and Physiology, Faculty of Medicine of the University of Porto, Porto, Portugal; Heart Failure Clinic, Internal Medicine Department, Centr…
- UnIC@RISE, Cardiovascular Research and Development Center, Department of Surgery and Physiology, Faculty of Medicine of the University of Porto, Porto, Portugal; Internal Medicine Department, Centro Hospitalar Universit…
- Endocrinology Department, Centro Hospitalar Universitário de São João, Porto, Portugal.
- UnIC@RISE, Cardiovascular Research and Development Center, Department of Surgery and Physiology, Faculty of Medicine of the University of Porto, Porto, Portugal; Endocrinology Department, Centro Hospitalar Universitário…
- Université de Lorraine, INSERM, Centre d'Investigations Cliniques Plurithématique 1433, and INSERM U1116, CHRU, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France.
- Department of Medicine, University of Michigan School of Medicine, Ann Arbor, MI, USA.
Zitieren
APA
Ferreira, J. P., Marques, P., Leite, A. R., Neves, J. S., Zannad, F., & Pitt, B. (2026). Mineralocorticoid Receptor Antagonists and Aldosterone Synthase Inhibitors: Agent Comparison With Implications for Clinical Practice and Trial Design. Journal of Cardiac Failure. https://doi.org/10.1016/j.cardfail.2025.05.002
Vancouver
Ferreira JP, Marques P, Leite AR, Neves JS, Zannad F, Pitt B. Mineralocorticoid Receptor Antagonists and Aldosterone Synthase Inhibitors: Agent Comparison With Implications for Clinical Practice and Trial Design. Journal of Cardiac Failure. 2026. doi:10.1016/j.cardfail.2025.05.002
BibTeX
@article{Ferreira2026,
author = {Ferreira, João Pedro and Marques, Pedro and Leite, Ana Rita and Neves, João Sérgio and Zannad, Faiez and Pitt, Bertram},
title = {Mineralocorticoid Receptor Antagonists and Aldosterone Synthase Inhibitors: Agent Comparison With Implications for Clinical Practice and Trial Design},
journal = {Journal of Cardiac Failure},
year = {2026},
doi = {10.1016/j.cardfail.2025.05.002}
}
EUVIMED